Abstract:Soraya Thantaviriya, 1 Nanticha Kamanamool, 2 Titiporn Sansureerungsikul, 3 Montree Udompataikul, 1 Supason Wanichwecharungruang, 3 Salinee Rojhirunsakool 1 1 Department of Dermatology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand; 2 Department of Preventive and Social Medicine, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand; 3 Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand Correspondence: Salinee Rojhirunsakool, Department of Dermatology, Faculty of Medicine, Srinakharinwirot University, 114 Sukhumvit 23, Wattana District, Bangkok, 10110, Thailand, Tel +66894159665, Email Background: Detachable microneedles (DMNs) are dissolvable microneedles that detach from the base during administration. The use of DMNs-containing steroids for acne has never been investigated. Methods: Thirty-five patients with facial inflammatory acne were evaluated for acne treatment efficacy and safety of DMNs and DMNs containing triamcinolone acetonide (TA) via a 28-day randomized, double-blind, controlled trial. Four inflammatory acne lesions were selected from each participant and randomly treated with a single application of 700 μm DMNs containing 262.02 ± 15.62 μg TA (700DMNTA), 1000 μm DMNs containing 160.00 ± 34.92 μg TA (1000DMNTA), 700 μm DMN without TA (700DMN), and a control. Efficacy was measured by assessing physical grading, diameter, volume, erythema index, and melanin index. Safety was evaluated by assessing reports of adverse effects from patients and physicians. Results: All three treatment groups achieved resolution of inflammatory acne significantly faster than the control group, with median times for resolution of 4.6, 5.25, 6.7, and 8.1 days in the 1000DMNTA, 700DMNTA, 700DMN, and control, respectively. When compared to the control group, the diameters and post-acne erythema of inflammatory acne were significantly reduced in the treatment groups. The 1000DMNTA decreased acne size and erythema more than other treatments. DMNTA also tended to decrease acne size and erythema more than DMN with no TA, but there was no statistically significant difference. All participants preferred DMN over conventional intralesional steroid injection due to less pain and self-application. No adverse effect was observed. Conclusion: DMNTA is a safe, effective alternative treatment for inflammatory acne and significantly reduces post-acne erythema. Keywords: acne vulgaris, microneedle drug delivery, intralesional steroid, steroid injection, acne adjunctive treatment Acne is one of the most common skin diseases worldwide affecting quality of life. 1 It mostly occurs during adolescence and can persist into adulthood with life-time prevalence of about 85%. 1,2 Inflammatory acne is painful, uncomfortable, and unsightly; therefore, people seek a fast and effective treatment to accelerate the healing of these inflammatory lesions. Topical and oral medications are first-line treatments for acne. 3–6 Unfortunately, these treatments are not effective in accelerating the resolution of inflammatory lesions once they occur. Intralesional steroid injection (ILS) has been commonly and widely used to treat inflammatory acne for many years. 7,8 It is recommended as an adjunctive treatment for large cysts and nodules when systemic medications may not always be effective. Another popular usage of ILS is for inflammatory acne, which effectively reduces inflammation and accelerates resolution of inflammatory lesions. 7 It is a way to directly access the lesion and cause dramatic flattening of most inflammatory acne. 8 However, it must be performed by medical personnel and is less accepted by patients due to pain and needle phobia. Furthermore, ILS is an operator-dependent procedure that needs skilled personnel to deliver effective treatment, and side effects such as skin atrophy, hypopigmentation, and infection can occur after treatment. 7–9 Various topical or transdermal delivery systems have been investigated for improving drug permeation through the skin. 10 The stratum corneum, which generally allows penetration of only small (400 Da) and lipophilic molecules, is the major barrier to transdermal drug delivery. 10,11 ILS, which uses a hypodermic needle, can bypass the stratum corneum and directly deposit the drug into the upper and deep dermis, where inflammatory acne lesions occur. Many drug delivery methods can enhance drug's penetration through the stratum corneum, such as topical enhancers and transdermal patches, however, they cannot deliver drugs directly to the lesion in the dermis. Microneedles -Abstract Truncated-

DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial

A Multicentre, Randomized, Single-Blind Comparison of Topical Clindamycin 1%/benzoyl Peroxide 5% Once-Daily Gel Versus Clindamycin 1% Twice-Daily Gel in the Treatment of Mild to Moderate Acne Vulgaris in Chinese Patients.

An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color

Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study

The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator‐blinded comparative study

Efficacy of ceramides and niacinamide‐containing moisturizer versus hydrophilic cream in combination with topical anti‐acne treatment in mild to moderate acne vulgaris: A split face, double‐blinded, randomized controlled trial

Twelve Week Study Evaluating the Efficacy of a Novel Standardized Nutraceutical to Improve Acne and Skin Health

Effectiveness and Safety of a Dermocosmetic Cream as an Adjunct to Adapalene for Mild and Moderate Acne in Indonesia: Results of a Multicenter Randomized Controlled Study

A Pilot Study on the Comparative Efficacy and Tolerability of a Novel Dermo-cosmetic Cream with 15% Azelaic Acid for Mild to Moderate Acne: A New Approach to Acne Treatment

A Seven-week, Open-label Trial Evaluating the Safety and Efficacy of a Photopneumatic Device for Mitigating Mild-to-Moderate Acne in Healthy Adolescents and Young Adults

A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris

Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial

A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne

Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.

Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris

Role of vitamin D supplement adjunct to topical benzoyl peroxide in acne: a randomized double-blinded controlled study

Efficacy and Safety of Detachable Microneedle Patch Containing Triamcinolone Acetonide in the Treatment of Inflammatory Acne

A Systematic Literature Review and Network Meta-Analysis of Comparative Efficacy of Topical Fixed-Dose Combination Treatments for Moderate to Severe Acne Vulgaris

Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study

Efficacy of a twice-daily, 3-step, over-the-counter skincare regimen for the treatment of acne vulgaris

Study of different pre-treatments in the comparison of the efficacy of photodynamic therapy for moderate to severe acne vulgaris